P1, N=93, Terminated, Bio-Thera Solutions | N=250 --> 93 | Trial completion date: Jul 2026 --> Mar 2026 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2025 --> Aug 2025; Due to the adjustment of our company's research and development strategy, we are now prematurely terminating this project.

9 days ago

Enrollment change • Trial completion date • Trial termination • Trial primary completion date

BAT8007

9ms

BAT-8007-001-CR: To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)

P1, N=250, Active, not recruiting, Bio-Thera Solutions | Recruiting --> Active, not recruiting

9 months ago

Enrollment closed

BAT8007

1year

BAT-8007-001-CR: To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)

P1, N=250, Recruiting, Bio-Thera Solutions | Trial completion date: Jul 2025 --> Jul 2026 | Trial primary completion date: Dec 2024 --> Dec 2025

1 year ago

Trial completion date • Trial primary completion date

BAT8007

almost2years

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)

P1, N=250, Recruiting, Bio-Thera Solutions | N=42 --> 250

almost 2 years ago

Enrollment change • Metastases

BAT8007

almost3years

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)

P1, N=42, Recruiting, Bio-Thera Solutions

almost 3 years ago

New P1 trial • Metastases

BAT8007